VEMURAFENIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 188 adverse event reports in the FDA FAERS database where VEMURAFENIB was used for Neoplasm malignant.
Most Reported Side Effects for VEMURAFENIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Rash | 1,202 | 14.0% | 52 | 239 |
| Arthralgia | 783 | 9.2% | 27 | 79 |
| Off label use | 782 | 9.1% | 90 | 120 |
| Fatigue | 773 | 9.0% | 37 | 122 |
| Diarrhoea | 655 | 7.7% | 51 | 225 |
| Nausea | 601 | 7.0% | 46 | 137 |
| Pyrexia | 569 | 6.7% | 33 | 299 |
| Death | 505 | 5.9% | 504 | 37 |
| Alopecia | 445 | 5.2% | 8 | 32 |
| Decreased appetite | 383 | 4.5% | 22 | 79 |
| Vomiting | 342 | 4.0% | 36 | 141 |
| No adverse event | 341 | 4.0% | 3 | 2 |
| Photosensitivity reaction | 321 | 3.8% | 20 | 64 |
| Pruritus | 305 | 3.6% | 13 | 54 |
| Sunburn | 292 | 3.4% | 7 | 24 |
Other Indications for VEMURAFENIB
Malignant melanoma (2,548)
Product used for unknown indication (2,079)
Metastatic malignant melanoma (1,848)
Hairy cell leukaemia (236)
Langerhans' cell histiocytosis (146)
Thyroid cancer (119)
Colon cancer (110)
Erdheim-chester disease (108)
Malignant melanoma stage iv (88)
Brain neoplasm malignant (68)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)